Skip to content

Neogen NEOG Enterprise value

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$45B+30.0%
Zoetis logo
ZoetisZTS
$57.95B-26.4%
Revvity logo
RevvityRVTY
$12.88B-13.7%
TEC
Bio-TechneTECH
$8.26B-13.6%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's enterprise value?
Neogen (NEOG) reported enterprise value of $3.08B in Q4 2025.
How has Neogen's enterprise value changed year-over-year?
Neogen's enterprise value increased by 4.4% year-over-year, from $2.95B to $3.08B.
What is the long-term trend for Neogen's enterprise value?
Over 4 years (2021 to 2025), Neogen's enterprise value has grown at a -18.9% compound annual growth rate (CAGR), from $4.9B to $2.12B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.